Intravitreal Ranibizumab Injection In Aggressive Retinopathy Of Prematurity Compared With Type 1 Prethreshold Retinopathy Of Prematurity

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05701124

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:49.162986+00:00

Published At

2023-01-30T00:00:00+00:00

Record Updated At

2023-01-30

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Retina Disease", "Retinopathy of Prematurity", "Ranibizumab"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2023-01-30"

protocolSection.identificationModule.nctId

"NCT05701124"

protocolSection.identificationModule.officialTitle

"Intravitreal Ranibizumab Injection In Aggressive Retinopathy Of Prematurity Compared With Type 1 Prethreshold Retinopathy Of Prematurity"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Retina Disease (protocolSection.conditionsModule.conditions)
• Retinopathy of Prematurity (protocolSection.conditionsModule.conditions)
• Ranibizumab (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.